Back to search

Article

Small molecule-induced ERBB4 activation to treat heart failure

2024-04-08

Abstract excerpt

<title>Abstract</title> <p>Heart failure is a common and deadly disease, requiring new therapeutic approaches. The neuregulin-1 (NRG1)/erythroblastic leukemia viral oncogene homolog 4 (ERBB4) pathway is an interesting target because of its cardioprotective effects. The therapeutic use of recombinant NRG1 has been difficult, because it requires intravenous administration and is non-selective for the ERBB4 receptor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
620ab4d1-a7a8-572f-9c5a-f30be0c93f99
DOI
10.21203/rs.3.rs-4175488/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Small molecule-induced ERBB4 activation to treat heart failureDOI 10.21203/rs.3.rs-4175488/v1
Select a neighboring publication to make it the new centre.